Schedule 13G ownership disclosure
Cognition Therapeutics Inc
Security class unavailable · CUSIP: 19243B102
Event date: 2023-10-13
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,205,377
- Percent of class
- 7.5300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-24-000333
- Form type
- SC 13G
- Filer
- COGNITION THERAPEUTICS INC
- CIK
- CIK 1455365
- Filed
- Jan 19, 2024
- Reporting period
- Oct 13, 2023
- Description
- Schedule 13G beneficial ownership